1. 21 Code of Federal Regulations 201.vol. 56(a).
2. Rx package inserts: redesigned with fewer errors in mind: the first PI makeover in 25 years adds" highlights" and adverse event hotlines;Fass;J Fam Pract,2007
3. Requirements on content and format of labeling for human prescription drug and biological products;US Food and Drug Administration;Fed Regist,2006
4. Lost in transmission—FDA drug information that never reaches clinicians;Schwartz;N Engl J Med,2009
5. Highlights of drug package inserts and the website DailyMed: the need for further improvement in package inserts to help busy prescribers;de Leon;J Clin Psychopharmacol,2011